Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

DCAT Week ’17 Announcement Forum: Patheon Discusses Acquisition of Former Roche API Manufacturing Facility
By

By
Andreas Stolle, PhD Vice President, API Process Development ServicesPatheon Andreas Stolle, PhD, Vice President, API Process Development Services, Patheon, discussed how the company is integrating its most recent acquisition into…

DCAT Week ’17 Announcement Forum: Olon Highlights Integration of Infa
By

By
Giorgio BertoliniSenior Vice President, Research & Development, Chemistry, Olon S.p.A. Giorgio Bertolini, Senior Vice President, Research & Development, Chemistry. Olon S.p.A, outlined the integration of the Infa Group, which Olon…

DCAT Week ’17: Noramco CEO Discusses Strategy as Stand-Alone Company
By

By
James MishPresident & CEO Noramco James Mish, President and CEO of Noramco, provided the strategic direction of the company following its divestment by Johnson & Johnson in July 2016 and…

DCAT Week ’17 Announcement Forum: Mayne Pharma Specifies Timeline for $80-Million Expansion
By

By
Kimberly McClintock Executive Vice President, Metrics Contract Services Mayne Pharma Metrics Contract Services and its parent, Mayne Pharma, are constructing an $80-million commercial pharmaceutical manufacturing facility as part of a…

DCAT Week ’17 Announcement Forum: Datwyler Outlines $100-Million Manufacturing Expansion
By

By
Megan Williamson Vice President, Injection SystemsDatwyler The Datwyler Group is proceeding with a $100-million investment for a new manufacturing facility for elastomer components, outlined Megan Williamson, Vice President, Injection Systems, Datwyler…

DCAT Week ’17 Announcement Forum: Lubrizol’s Particle Sciences Proceeds With Manufacturing Expansion
By

By
Mark Mitchnick, MDCEOLubrizol’s Particle Sciences Mark Mitchnick, MD, Chief Executive Officer, Particle Sciences, a Lubrizol company, outlined the company’s recent investment in commercial manufacturing, the latest in a series of…

DCAT Week ’17 Announcement Forum: CordenPharma Expands Oligonucletide API and Sterile Injectables Manufacturing Capacity
By

By
Mimoun Ayoub, PhD Director, Global Peptides, Oligonucleotides, Lipids, Carbohydrates & Injectables Platforms CordenPharma Corden Pharma is expanding into oligonucleotide active pharmaceutical ingredient (API) manufacturing, which is supported by a growing clinical…

DCAT Week ’17 Announcement Forum: CMC Biologics Updates Acquisition by AGC Asahi Glass
By

By
Robert Broeze, PhD Chief Business Officer CMC Biologics Robert Broeze, PhD, Chief Business Officer. CMC Biologics, outlined the operational focus for the company following the company’s acquisition by AGC Asahi…

DCAT Week ’17 Announcement Forum: Catalent Discusses Integration of Pharmatek and Accucaps Acquisitions
By

By
Elliott Berger Vice President, Global StrategyCatalent Pharma Solutions Elliott Berger, Vice President, Global Strategy, Catalent Pharma Solutions, highlighted the rationale and integration of two recent acquisitions by the company (Accucaps and…

DCAT Week ’17 Announcement Forum: BioVectra Outlines API Manufacturing Expansion
By

By
Marc SauerVice President, Research and DevelopmentBioVectra In 2017, BioVectra will complete its fourth GMP intermediate and active pharmaceutical ingredient (API) manufacturing facility in Atlantic Canada, outlined Marc Sauer, VIce President,…